As the Democratic presidential candidates prepare to discuss Oct. 10, Endocrine Society spokesman Joshua Safer, MD, is available to comment on transgender health and the benefits of increased access to care.

Safer is the Executive Director of the Mount Sinai Center for Transgender Medicine and Surgery (CTMS) and Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He can provide context on:

  • The for treating transgender patients
  • Gender-affirming treatment’s health and quality of life benefits and why insurers should cover these interventions
  • Research gaps and needed to optimize care

Please contact [email protected] to schedule an interview with Dr. Safer.

MEDIA CONTACT
Register for reporter access to contact details
TYPE OF ARTICLE
Expert Pitch
SECTION
CHANNELS
Healthcare LGBTQ Issues
KEYWORDS
Transgender Town Hall LGBTQ Access To Care Policy
COMMENTS | COMMENTING POLICY